Apeloa Pharmaceutical Co., Ltd. engages in research, development, and production of active pharmaceutical ingredient (API) intermediates, contract development and production services (CDMO), and preparations. The products are mainly concentrated in cardio-cerebrovascular, anti-infection, anti-tumor and other treatment areas. Its products include preparation, raw material intermediates and veterinary drugs. Apeloa Pharmaceutical was founded on May 6, 1997 and is headquartered in Jinhua, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company